D-0773-2022 Class II Terminated
FDA drug recall D-0773-2022 was initiated by Preferred Pharmaceuticals, Inc. on Mar 24, 2022 and is designated Class II. Reason for recall: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program. The recall status is terminated (terminated Oct 25, 2023). Affected quantity: 528 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 27, 2022
- Initiation Date
- Mar 24, 2022
- Termination Date
- Oct 25, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 528 bottles
Product Description
Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical, Preferred Pharmaceuticals, Inc., The Physicians Solutions, NDC 68788-7918-01
Reason for Recall
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.
Distribution Pattern
Nationwide within the USA.
Code Information
Lots: E1220B, Exp.: 01/31/2023; F0220M, Exp.: 3/31/2023; F2320A, Exp.: 3/31/2023; F3020M, Exp.: 3/31/2023; G0920Q, Exp.: 3/31/2023; C0821M, Exp.: 1/31/2024; J1920, Exp.: 5/31/2023; E2421j, Exp.: 4/30/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0773-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026